(Q52068190)

21 April 2018

title

[99mTc]-HM-PAO SPECT in Parkinson's disease. (English)

1 reference

21 April 2018

1 reference

Pizzolato G

1

1 reference

21 April 2018

Dam M

2

1 reference

21 April 2018

Borsato N

3

1 reference

21 April 2018

Saitta B

4

1 reference

21 April 2018

Da Col C

5

1 reference

21 April 2018

Perlotto N

6

1 reference

21 April 2018

Zanco P

7

1 reference

21 April 2018

Ferlin G

8

1 reference

21 April 2018

Battistin L

9

1 reference

21 April 2018

publication date

1 December 1988

1 reference

21 April 2018

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

21 April 2018

volume

8

1 reference

21 April 2018

issue

6

1 reference

21 April 2018

page(s)

S101-8

1 reference

21 April 2018

Metabolic aspects of aging brain and related disorders

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Parkinson disease, dementia, and Alzheimer disease: clinicopathological correlations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Cerebral blood flow in severity-matched Alzheimer and multi-infarct patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Positron emission tomography in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Alzheimer's disease: focal cortical changes shown by positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Cerebral blood flow and cognitive impairment in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Dementia in Parkinson disease: A neuropathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

The diagnosis of dementia with single photon emission computed tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Is the mesocortical dopaminergic system involved in Parkinson disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Patterns of local cerebral glucose utilization determined in Parkinson's disease by the [18F]fluorodeoxyglucose method

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

The retention of [99mTc]-d,l-HM-PAO in the human brain after intracarotid bolus injection: a kinetic analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Brain dopamine metabolism in patients with Parkinson's disease measured with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Regional impairment of cerebral oxidative metabolism in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Distribution of high affinity sodium-independent [3H]gamma-aminobutyric acid [3H]GABA binding in the human brain: alterations in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Decreased cortical glucose utilization after ibotenate lesion of the rat ventromedial globus pallidus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Aging and Extrapyramidal Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Regional blood flow in hemiparkinsonism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Stimulatory effect of the D2 antagonist sulpiride on glucose utilization in dopaminergic regions of rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Haloperidol and cerebral metabolism in the conscious rat: relation to pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Time-course and regional distribution of the metabolic effects of bromocriptine in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Arecoline-induced elevations of regional cerebral metabolism in the conscious rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Basal forebrain neurons in the dementia of Parkinson disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Alterations of regional cerebral blood flow and oxygen metabolism in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

Glucose utilization in the Papez circuit: effects of oxotremorine and scopolamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

7 January 2021

Effects of oxotremorine on local glucose utilization in the rat cerebral cortex.

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

7 January 2021

Regional cerebral blood flow in hemiparkinsonian patients. Emission computerized tomography of inhaled 133Xenon before and after levodopa

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

7 January 2021

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

1 reference

7 January 2021

https://api.crossref.org/works/10.1038%2FJCBFM.1988.39

1 reference

7 January 2021

Identifiers

DOI

10.1038/JCBFM.1988.39

1 reference

21 April 2018

1 reference

21 April 2018